- EINSTEIN study, rivaroxaban in the treatment of deep vein thrombosis2011 | Second Faculty of Medicine
- Rivaroxaban in atrial fibrillation2014 | Second Faculty of Medicine
- EINSTEIN-PE study - rivaroxaban in the treatment of pulmonary embolism2012 | Second Faculty of Medicine
- Introduction to commentary on rivaroxaban +12009 | Faculty of Medicine in Hradec Králové
- Position of rivaroxaban in current medicine2014 | Third Faculty of Medicine
- Rivaroxaban - metabolism, pharmacologic properties and drug interactions2019 | First Faculty of Medicine
- Rivaroxaban - 4 year experience in the treatment of deep vein thrombosis2016 | Faculty of Medicine in Hradec Králové
- Rivaroxaban - a newly marketed antithrombotic agent2009 | First Faculty of Medicine
- Profile drug rivaroxaban - a new oral anticoagulants2014 | First Faculty of Medicine
- Rivaroxaban in clinical practice2013 | First Faculty of Medicine
- Rivaroxaban in patients with malignancy and venous thromboembolism - results of a randomized SELECT-D study2019 | First Faculty of Medicine
- Rivaroxaban versus Enoxaparin for thromboprophylaxis after hip arthroplasty2008 | Central Library of Charles University
- Rivaroxaban versus Enoxaparin for thromboprophylaxis after hip arthroplasty2008 | First Faculty of Medicine, Faculty of Medicine in Pilsen
- Rivaroxaban versus Enoxaparin for thromboprophylaxis after total knee arthroplasty2008 | Central Library of Charles University
- Rivaroxaban versus Enoxaparin for thromboprophylaxis after total knee arthroplasty2008 | First Faculty of Medicine, Faculty of Medicine in Pilsen
- Guidelines of Czech Association for Thrombosis and Haemostasis of the Czech Medical Association of J. E. Purkyně for safety treatment with new oral anticoagulants (NOAC) - dabigatran etexilate, apixaban and rivaroxaban2015 | First Faculty of Medicine
- PIONEER AD-PCI trial: rivaroxaban in the therapy of atrial fibrillation patients undergoing percutaneous coronary intervention2017 | Publication without faculty affiliation
- Direct factor Xa inhibitor rivaroxaban2009 | Faculty of Medicine in Hradec Králové
- Conservative treatment of chronic disseminated intravascular coagulation caused by chronic dissection and aneurysm of thoracoabdominal aorta with rivaroxaban2022 | Faculty of Medicine in Hradec Králové
- Rivaroxabanx2008 | First Faculty of Medicine
- Analysis of data from the EINSTEIN project2013 | Second Faculty of Medicine
- Comment on EINSTEIN study2011 | Faculty of Medicine in Hradec Králové
- Andexanet alfa - specific antidote to severe bleeding after a treatment with apixaban or rivaroxaban2020 | Publication without faculty affiliation
- Comparison of new oral anticoagulants from the perspective of pharmacological features and clinical trials2013 | First Faculty of Medicine, Third Faculty of Medicine
- Research Report University Hospital clinical trial RIVAROXHFA3001Publication without faculty affiliation
- Laboratory monitoring of new direct anticoagulants2014 | First Faculty of Medicine
- Anticoagulation with new antithrombotic agents - recommendations for daily practice2013 | Publication without faculty affiliation
- Final report of University Hospital Hradec Kralove to the clinical trial protocol no. COMPASS 15786Publication without faculty affiliation
- New therapeutic approach to therapy of deep venous thrombosis2013 | Faculty of Medicine in Hradec Králové